151 related articles for article (PubMed ID: 12671842)
1. Inflammation in ESRD: causes and potential consequences.
Kaysen GA; Kumar V
J Ren Nutr; 2003 Apr; 13(2):158-60. PubMed ID: 12671842
[TBL] [Abstract][Full Text] [Related]
2. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and effects of inflammation in end-stage renal disease.
Kaysen GA; Eiserich JP
Semin Dial; 2003; 16(6):438-46. PubMed ID: 14629602
[TBL] [Abstract][Full Text] [Related]
5. Assessment of inflammation and nutrition in patients with end-stage renal disease.
Don BR; Kaysen GA
J Nephrol; 2000; 13(4):249-59. PubMed ID: 10946803
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
[TBL] [Abstract][Full Text] [Related]
7. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
8. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
9. [Inflammation and nutritional status in haemodialysis patients].
Tirmenstajn-Janković B; Dimković N; Zivanović M
Med Pregl; 2007; 60 Suppl 2():137-41. PubMed ID: 18928180
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.
Yoon SH; Choi NW; Yun SR
Nephron Clin Pract; 2009; 111(1):c1-6. PubMed ID: 19023220
[TBL] [Abstract][Full Text] [Related]
11. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
Efendic E; Lindholm B; Bergström J; Stenvinkel P
Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in end-stage renal disease: the hidden enemy.
Stenvinkel P
Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
[TBL] [Abstract][Full Text] [Related]
14. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
15. Albumin synthesis, catabolism and distribution in dialysis patients.
Kaysen GA; Yeun J; Depner T
Miner Electrolyte Metab; 1997; 23(3-6):218-24. PubMed ID: 9387121
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
17. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
[TBL] [Abstract][Full Text] [Related]
18. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin: relationship to inflammation and nutrition.
Don BR; Kaysen G
Semin Dial; 2004; 17(6):432-7. PubMed ID: 15660573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
